First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $229.01 and last traded at $229.0890, with a volume of 3758 shares changing hands. The stock had previously closed at $226.09.
First Trust NYSE Arca Biotechnology Index Fund Price Performance
The firm’s 50-day moving average price is $209.61 and its 200-day moving average price is $208.84. The stock has a market cap of $2.54 billion, a P/E ratio of 21.72 and a beta of 0.68.
Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund
Several hedge funds have recently bought and sold shares of FBT. High Point Wealth Management LLC bought a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter worth about $26,000. Russell Investments Group Ltd. grew its holdings in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after buying an additional 158 shares in the last quarter. Rossby Financial LCC increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 160.0% in the 3rd quarter. Rossby Financial LCC now owns 169 shares of the company’s stock worth $31,000 after acquiring an additional 104 shares during the last quarter. AG Campbell Advisory LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter worth approximately $31,000. Finally, Capital Investment Advisory Services LLC raised its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 63.1% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock worth $32,000 after acquiring an additional 70 shares in the last quarter.
First Trust NYSE Arca Biotechnology Index Fund Company Profile
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Chewy’s Growth Engine Is Stronger Than the Market Thinks
- Nebius Group’s £1.7 Billion UK Expansion Fuels Bullish Case Despite the Pullback
- An Analyst Just Raised Tesla’s Price Target by 227%—Here’s Why
- AST SpaceMobile’s SpaceX Catalyst Could Come With a Volatility Warning
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
